Cargando…
ITULAZAX(®) versus Alutard SQ(®) in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective
BACKGROUND AND AIMS: Allergic rhinitis (AR) is an inflammatory disorder triggered by an allergic immune response to inhaled allergens. Birch pollen is the major allergenic tree pollen in parts of Europe. ITULAZAX® is a sublingual immunotherapy tablet for the treatment of adults with moderate‐to‐seve...
Autores principales: | Rønborg, Steen M., Grand, Tobias Sydendal, Brandi, Henrik, Pollock, Richard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631325/ https://www.ncbi.nlm.nih.gov/pubmed/36434741 http://dx.doi.org/10.1002/clt2.12196 |
Ejemplares similares
-
A Cost-Utility Analysis of SQ(®) Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
por: Pollock, Richard F, et al.
Publicado: (2023) -
Cost-Effectiveness Of The SQ(®) Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
por: Vogelberg, Christian, et al.
Publicado: (2019) -
Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018) -
Allergen-specific immunotherapy with Alutard SQ improves allergic inflammation in house-dust mites-induced allergic asthma rats through inactivation of the HMGB1/TLR4/NF-κB pathway
por: Zhai, Yingying, et al.
Publicado: (2023) -
Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma
por: Kämpe, Mary, et al.
Publicado: (2007)